Site search
2887 results for '' found
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis (NCT02914535)
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis (NCT02914535)
/
Fibrinogen Early in Severe Trauma StudY II (NCT05449834)
Fibrinogen Early in Severe Trauma StudY II (NCT05449834)
/
Evaluating a telehealth exercise model of care for adults with CF: A feasibility randomised controlled trial (ACTRN12625000116426)
Evaluating a telehealth exercise model of care for adults with CF: A feasibility randomised controlled trial (ACTRN12625000116426)
/
Imaging Astrogliosis in Patients with Epilepsy with [18F]-FDED PET (ACTRN12625000170426)
Imaging Astrogliosis in Patients with Epilepsy with [18F]-FDED PET (ACTRN12625000170426)
/
An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participa
An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participa
/
Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke (NCT05203224)
Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke (NCT05203224)
/
Post-thrombectomy intra-arterial tenecteplase for Acute manaGement of Non-retrievable thrombus and no-reflow in Emergent Stroke (NCT05892510)
Post-thrombectomy intra-arterial tenecteplase for Acute manaGement of Non-retrievable thrombus and no-reflow in Emergent Stroke (NCT05892510)
/
Evolut™ EXPAND TAVR II Pivotal Trial (NCT05149755)
Evolut™ EXPAND TAVR II Pivotal Trial (NCT05149755)
/
Exercise as an immunomodulatory intervention and adjuvant to vaccination in people with COPD: feasibility randomised controlled trial. (ACTRN12624000372583)
Exercise as an immunomodulatory intervention and adjuvant to vaccination in people with COPD: feasibility randomised controlled trial. (ACTRN12624000372583)
/